ReviewERJ open research2022
International consensus on lung function testing during the COVID-19 pandemic and beyond.
Review in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 43 citations in OpenAlex.
- Predictive Accuracy of Serum N-Terminal Pro-B-Type Natriuretic Peptide Alone and in Combination with Respiratory Function Tests to Identify Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).Diagnostics (Basel, Switzerland) · 2026Article
- COVID-19 and its impact on healthcare services provided to patients with COPD: a qualitative study.BMJ open respiratory research · 2025Article
- Nationwide Assessment of Pulmonary Function Testing Practices and Safety Compliance During the COVID-19 PandemicThoracic research and practice · 2025Article
- The Global Burden of Obstructive Sleep Apnea.Diagnostics (Basel, Switzerland) · 2025Review
- Respiratory functions, respiratory muscle strength and fatigue in patients with pediatric-onset multiple sclerosis: a comparative cross-sectional study.Acta neurologica Belgica · 2025Observational
- Impact of viral filters on accuracy of cardiopulmonary testing and spirometry.ERJ open research · 2024Article
- Remotely supervised spirometry versus laboratory-based spirometry during the COVID-19 pandemic: a retrospective analysis.Respiratory research · 2024Article
- Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.ERJ open research · 2024Article
- Review
- Lung Function Tests in Infants and Children.Indian journal of pediatrics · 2023Review
- What Have We Learned About Transmission of Coronavirus Disease-2019: Implications for Pulmonary Function Testing and Pulmonary Procedures.Clinics in chest medicine · 2023Review
- Recent developments in the immunopathology of COVID-19.Allergy · 2023Review
- Pulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement.Respirology (Carlton, Vic.) · 2022Review
- Telemedicine and virtual respiratory care in the era of COVID-19.ERJ open research · 2022Review
- Re-opening the pediatric pulmonary function laboratory during the ongoing COVID-19 pandemic.Paediatric respiratory reviews · 2022Review
- [National Survey on the Activity of Lung Function Laboratories. Effects During the SARS-COV-2 Pandemic].Open respiratory archivesArticle
- [Risk Management in Performing Post-Pandemic Pulmonary Function Tests].Open respiratory archivesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 18 institutions in 10 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2019 (COVID-19) has negatively affected the delivery of respiratory diagnostic services across the world due to the potential risk of disease transmission during lung function testing. Community prevalence, reoccurrence of COVID-19 surges and the emergence of different variants of SARS-CoV-2 have impeded attempts to restore services. Finding consensus on how to deliver safe lung function services for both patients attending and for staff performing the tests are of paramount importance. This international statement presents the consensus opinion of 23 experts in the field of lung function and respiratory physiology balanced with evidence from the reviewed literature. It describes a robust roadmap for restoration and continuity of lung function testing services during the COVID-19 pandemic and beyond. Important strategies presented in this consensus statement relate to the patient journey when attending for lung function tests. We discuss appointment preparation, operational and environmental issues, testing room requirements including mitigation strategies for transmission risk, requirement for improved ventilation, maintaining physical distance and use of personal protection equipment. We also provide consensus opinion on precautions relating to specific tests, filters, management of special patient groups and alternative options to testing in hospitals. The pandemic has highlighted how vulnerable lung function services are and forces us to re-think how long-term mitigation strategies can protect our services during this and any possible future pandemic. This statement aspires to address the safety concerns that exist and provide strategies to make lung function tests and the testing environment safer when tests are required.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.